Fundies.
English

Segment disclosures

Company overview

Sarepta Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

All Other Segments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30401251000 USD20260805Open filing evidence
2026-01-01 – 2026-06-301132054000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31730803000 USD20260506Open filing evidence
2025-01-01 – 2025-12-312198237000 USD20260302Open filing evidence
2025-07-01 – 2025-09-30399356000 USD20251106Open filing evidence
2025-01-01 – 2025-09-301755303000 USD20251106Open filing evidence
2025-04-01 – 2025-06-30611091000 USD20260805Open filing evidence
2025-01-01 – 2025-06-301355947000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31744856000 USD20260506Open filing evidence
2024-01-01 – 2024-12-311901979000 USD20260302Open filing evidence
2024-07-01 – 2024-09-30467172000 USD20251106Open filing evidence
2024-01-01 – 2024-09-301243567000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30362931000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30776395000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31413464000 USD20250506Open filing evidence
2023-01-01 – 2023-12-311243336000 USD20260302Open filing evidence
2022-01-01 – 2022-12-31933013000 USD20250228Open filing evidence